Buerger's disease

(redirected from thromboangiitis obliterans)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.
Related to thromboangiitis obliterans: arteriosclerosis obliterans

Buerger's disease

[′bər·gərz di‚zēz]
References in periodicals archive ?
Chen et al., "Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors," British Journal of Pharmacology, vol.
Buerger, "Thromboangiitis obliterans: a study of the vascular lesions leading to presenile gangrene," The American Journal of the Medical Sciences, vol.
Enrolled CLI patients were either suffering from atherosclerotic PAD or Thromboangiitis Obliterans (TAO), also known as Buerger's disease.
Buerger's disease, also called thromboangiitis obliterans (TAO), is a recurrent vaso-occlusive disease.
Gu, "Tong-Sai-Mai tablet in the treatment of thromboangiitis obliterans and other occlusive vascular diseases 150 example clinical curative effect and its mechanism," Journal of Nanjing College of Traditional Chinese Medicine, no.
As in many other rather uncommon diseases, the diagnosis of PV may be overlooked unless it is explicitly considered, and it is likely that many cases are never correctly diagnosed but rather masquerade under the diagnosis of various types of peripheral vascular disease including thromboangiitis obliterans (Burger's disease), atypical erythromelalgia, or hypertension.
Absolute contraindications include an inadequate circulation to the extremity, Raynaud syndrome, thromboangiitis obliterans (Buerger disease), full-thickness burn over insertion site and skin infection over insertion site; whereas uncontrolled coagulopathy, systemic anticoagulation, inadequate collateral flow from ulnar artery on Allen test and atherosclerosis are its relative contra-indications2,3.
(A notation is that it also acts against such vascular diseases as thromboangiitis obliterans, or Buerger's disease, and perhaps against arteriosclerosis--a potential option against angioplasty or heart bypass surgery.) An update is furnished by Jessica Marshall in the 12 January issue of NewScientist.
Additional exclusion criteria were PAD attributable to nonatherosclerotic causes (cardioembolic disease, thromboangiitis obliterans, vasculitis, or congenital or metabolic vascular disease) and a history or presence of any malignancy.
Vascular causes include thromboangiitis obliterans (Buerger's disease), and deep venous thrombosis.